Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
#SHAAD debuts Tuesday, August 20. Here’s how you can be part of the Southern Solution.
What’s your preferred way to get tested? Share it June 27 on social media with #DoingItMyWay.
Recent research shows about 1 in 4 people in the United States have fatty liver disease. Among Latinos, the rate is significantly higher.
Researchers compared liver-related death rates among Mexicans, Puerto Ricans and Cubans.
Higher liver-disease-related mortality is also seen in areas with lower average household income.
This is according to an analysis of hep C treatment rates at four large urban hospital systems.
Today is National Hispanic Hepatitis Awareness Day; the Latino Commission on AIDS is hosting webinars during Hepatitis Awareness Month.
Highlights from HIV and hepatitis C research presented at the 2018 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston
Fourteen years after collapsing onstage due to hep C–related complications, Alejandro Escovedo has launched his career as an advocate.
A joint statement from the Infectious Diseases Society of America and the HIV Medicine Association to President Trump and Congress.
However, treating hepatitis C appears to erase these disparities.
Real-world data showed Merck’s hep C regimen performed well among a population with genotypes 1 or 4 and multiple other health conditions.
White heroin users are injecting at higher rates and are less likely to use harm reduction programs than their minority counterparts.
An average of four to 10 years earlier than their white and black counterparts.
Black women living with HIV and hepatitis C are less likely to die of liver disease, compared with coinfected white and Latina women
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.